AMERICAN JOURNAL OF CLINICAL PATHOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2179216, encodeId=cde021e92169e, content=11.6投稿 12.9修稿 12.14修回 12.29接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Jan 04 13:37:26 CST 2024, time=2024-01-04, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2154986, encodeId=142f21549861e, content=和病理相关的就行吗还是要以病理形态学为主 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c705729225, createdName=ms3000000555724543, createdTime=Mon Aug 28 17:40:02 CST 2023, time=2023-08-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2101893, encodeId=1c1321018936b, content=请问文章被接受了，想修改通讯作者地址可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b64882417, createdName=1186682916, createdTime=Tue Nov 22 09:01:32 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086418, encodeId=d55d1086418de, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086417, encodeId=6467108641ec7, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854192, encodeId=63dd85419249, content=投了一篇论文，大概两个月左右给了审稿意见，两位审稿人很专业很细致。要求半个月内返回修改稿，按照意见修改后，一周内接收。推荐病理方面的论文试一试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Fri Oct 11 09:31:49 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563762, encodeId=fe83563e6234, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：网上看到大家说这本杂志比较nice，就投了一篇免疫组化的文章。从投稿到外审拒稿只花了1个月的时间，两个外审专家的风格完全不同，第一个特别粗鲁，第二个特别nice，提出的问题也是比较零散。对语言的要求比较高，审稿周期还是很快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c1615298, createdName=Merlin4194, createdTime=Thu Nov 29 10:40:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847598, encodeId=21e184e59853, content=历史比较久的一个期刊，虽然近几年分数低了不少，还是一个很靠谱的期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Wed Oct 10 14:47:57 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539946, encodeId=330e53994612, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509113, encodeId=c217509113b3, content=这个杂志收录个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=559b1611420, createdName=lifan0819, createdTime=Tue Jan 13 18:27:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]

2024-01-04 凶巴巴恰北北怪兽来自塔斯马尼亚

11.6投稿
12.9修稿
12.14修回
12.29接受

15 0

[GetPortalCommentsPageByObjectIdResponse(id=2179216, encodeId=cde021e92169e, content=11.6投稿 12.9修稿 12.14修回 12.29接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Jan 04 13:37:26 CST 2024, time=2024-01-04, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2154986, encodeId=142f21549861e, content=和病理相关的就行吗还是要以病理形态学为主 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c705729225, createdName=ms3000000555724543, createdTime=Mon Aug 28 17:40:02 CST 2023, time=2023-08-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2101893, encodeId=1c1321018936b, content=请问文章被接受了，想修改通讯作者地址可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b64882417, createdName=1186682916, createdTime=Tue Nov 22 09:01:32 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086418, encodeId=d55d1086418de, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086417, encodeId=6467108641ec7, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854192, encodeId=63dd85419249, content=投了一篇论文，大概两个月左右给了审稿意见，两位审稿人很专业很细致。要求半个月内返回修改稿，按照意见修改后，一周内接收。推荐病理方面的论文试一试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Fri Oct 11 09:31:49 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563762, encodeId=fe83563e6234, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：网上看到大家说这本杂志比较nice，就投了一篇免疫组化的文章。从投稿到外审拒稿只花了1个月的时间，两个外审专家的风格完全不同，第一个特别粗鲁，第二个特别nice，提出的问题也是比较零散。对语言的要求比较高，审稿周期还是很快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c1615298, createdName=Merlin4194, createdTime=Thu Nov 29 10:40:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847598, encodeId=21e184e59853, content=历史比较久的一个期刊，虽然近几年分数低了不少，还是一个很靠谱的期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Wed Oct 10 14:47:57 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539946, encodeId=330e53994612, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509113, encodeId=c217509113b3, content=这个杂志收录个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=559b1611420, createdName=lifan0819, createdTime=Tue Jan 13 18:27:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]

2023-08-28 ms3000000555724543 来自安徽省

和病理相关的就行吗还是要以病理形态学为主

74 0

[GetPortalCommentsPageByObjectIdResponse(id=2179216, encodeId=cde021e92169e, content=11.6投稿 12.9修稿 12.14修回 12.29接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Jan 04 13:37:26 CST 2024, time=2024-01-04, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2154986, encodeId=142f21549861e, content=和病理相关的就行吗还是要以病理形态学为主 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c705729225, createdName=ms3000000555724543, createdTime=Mon Aug 28 17:40:02 CST 2023, time=2023-08-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2101893, encodeId=1c1321018936b, content=请问文章被接受了，想修改通讯作者地址可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b64882417, createdName=1186682916, createdTime=Tue Nov 22 09:01:32 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086418, encodeId=d55d1086418de, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086417, encodeId=6467108641ec7, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854192, encodeId=63dd85419249, content=投了一篇论文，大概两个月左右给了审稿意见，两位审稿人很专业很细致。要求半个月内返回修改稿，按照意见修改后，一周内接收。推荐病理方面的论文试一试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Fri Oct 11 09:31:49 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563762, encodeId=fe83563e6234, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：网上看到大家说这本杂志比较nice，就投了一篇免疫组化的文章。从投稿到外审拒稿只花了1个月的时间，两个外审专家的风格完全不同，第一个特别粗鲁，第二个特别nice，提出的问题也是比较零散。对语言的要求比较高，审稿周期还是很快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c1615298, createdName=Merlin4194, createdTime=Thu Nov 29 10:40:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847598, encodeId=21e184e59853, content=历史比较久的一个期刊，虽然近几年分数低了不少，还是一个很靠谱的期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Wed Oct 10 14:47:57 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539946, encodeId=330e53994612, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509113, encodeId=c217509113b3, content=这个杂志收录个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=559b1611420, createdName=lifan0819, createdTime=Tue Jan 13 18:27:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]

2022-11-22 1186682916

请问文章被接受了，想修改通讯作者地址可以吗

74 0

[GetPortalCommentsPageByObjectIdResponse(id=2179216, encodeId=cde021e92169e, content=11.6投稿 12.9修稿 12.14修回 12.29接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Jan 04 13:37:26 CST 2024, time=2024-01-04, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2154986, encodeId=142f21549861e, content=和病理相关的就行吗还是要以病理形态学为主 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c705729225, createdName=ms3000000555724543, createdTime=Mon Aug 28 17:40:02 CST 2023, time=2023-08-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2101893, encodeId=1c1321018936b, content=请问文章被接受了，想修改通讯作者地址可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b64882417, createdName=1186682916, createdTime=Tue Nov 22 09:01:32 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086418, encodeId=d55d1086418de, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086417, encodeId=6467108641ec7, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854192, encodeId=63dd85419249, content=投了一篇论文，大概两个月左右给了审稿意见，两位审稿人很专业很细致。要求半个月内返回修改稿，按照意见修改后，一周内接收。推荐病理方面的论文试一试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Fri Oct 11 09:31:49 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563762, encodeId=fe83563e6234, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：网上看到大家说这本杂志比较nice，就投了一篇免疫组化的文章。从投稿到外审拒稿只花了1个月的时间，两个外审专家的风格完全不同，第一个特别粗鲁，第二个特别nice，提出的问题也是比较零散。对语言的要求比较高，审稿周期还是很快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c1615298, createdName=Merlin4194, createdTime=Thu Nov 29 10:40:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847598, encodeId=21e184e59853, content=历史比较久的一个期刊，虽然近几年分数低了不少，还是一个很靠谱的期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Wed Oct 10 14:47:57 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539946, encodeId=330e53994612, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509113, encodeId=c217509113b3, content=这个杂志收录个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=559b1611420, createdName=lifan0819, createdTime=Tue Jan 13 18:27:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]

2021-12-29 msSSSSSD

引言三段式指的是什么?

76 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179216, encodeId=cde021e92169e, content=11.6投稿 12.9修稿 12.14修回 12.29接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Jan 04 13:37:26 CST 2024, time=2024-01-04, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2154986, encodeId=142f21549861e, content=和病理相关的就行吗还是要以病理形态学为主 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c705729225, createdName=ms3000000555724543, createdTime=Mon Aug 28 17:40:02 CST 2023, time=2023-08-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2101893, encodeId=1c1321018936b, content=请问文章被接受了，想修改通讯作者地址可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b64882417, createdName=1186682916, createdTime=Tue Nov 22 09:01:32 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086418, encodeId=d55d1086418de, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086417, encodeId=6467108641ec7, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854192, encodeId=63dd85419249, content=投了一篇论文，大概两个月左右给了审稿意见，两位审稿人很专业很细致。要求半个月内返回修改稿，按照意见修改后，一周内接收。推荐病理方面的论文试一试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Fri Oct 11 09:31:49 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563762, encodeId=fe83563e6234, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：网上看到大家说这本杂志比较nice，就投了一篇免疫组化的文章。从投稿到外审拒稿只花了1个月的时间，两个外审专家的风格完全不同，第一个特别粗鲁，第二个特别nice，提出的问题也是比较零散。对语言的要求比较高，审稿周期还是很快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c1615298, createdName=Merlin4194, createdTime=Thu Nov 29 10:40:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847598, encodeId=21e184e59853, content=历史比较久的一个期刊，虽然近几年分数低了不少，还是一个很靠谱的期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Wed Oct 10 14:47:57 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539946, encodeId=330e53994612, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509113, encodeId=c217509113b3, content=这个杂志收录个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=559b1611420, createdName=lifan0819, createdTime=Tue Jan 13 18:27:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

引言一般是三段式么？

107 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2179216, encodeId=cde021e92169e, content=11.6投稿 12.9修稿 12.14修回 12.29接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Jan 04 13:37:26 CST 2024, time=2024-01-04, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2154986, encodeId=142f21549861e, content=和病理相关的就行吗还是要以病理形态学为主 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c705729225, createdName=ms3000000555724543, createdTime=Mon Aug 28 17:40:02 CST 2023, time=2023-08-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2101893, encodeId=1c1321018936b, content=请问文章被接受了，想修改通讯作者地址可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b64882417, createdName=1186682916, createdTime=Tue Nov 22 09:01:32 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086418, encodeId=d55d1086418de, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086417, encodeId=6467108641ec7, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854192, encodeId=63dd85419249, content=投了一篇论文，大概两个月左右给了审稿意见，两位审稿人很专业很细致。要求半个月内返回修改稿，按照意见修改后，一周内接收。推荐病理方面的论文试一试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Fri Oct 11 09:31:49 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563762, encodeId=fe83563e6234, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：网上看到大家说这本杂志比较nice，就投了一篇免疫组化的文章。从投稿到外审拒稿只花了1个月的时间，两个外审专家的风格完全不同，第一个特别粗鲁，第二个特别nice，提出的问题也是比较零散。对语言的要求比较高，审稿周期还是很快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c1615298, createdName=Merlin4194, createdTime=Thu Nov 29 10:40:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847598, encodeId=21e184e59853, content=历史比较久的一个期刊，虽然近几年分数低了不少，还是一个很靠谱的期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Wed Oct 10 14:47:57 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539946, encodeId=330e53994612, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509113, encodeId=c217509113b3, content=这个杂志收录个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=559b1611420, createdName=lifan0819, createdTime=Tue Jan 13 18:27:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]

2019-10-11 ms4662714744603927

投了一篇论文，大概两个月左右给了审稿意见，两位审稿人很专业很细致。要求半个月内返回修改稿，按照意见修改后，一周内接收。推荐病理方面的论文试一试！

169 0

[GetPortalCommentsPageByObjectIdResponse(id=2179216, encodeId=cde021e92169e, content=11.6投稿 12.9修稿 12.14修回 12.29接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Jan 04 13:37:26 CST 2024, time=2024-01-04, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2154986, encodeId=142f21549861e, content=和病理相关的就行吗还是要以病理形态学为主 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c705729225, createdName=ms3000000555724543, createdTime=Mon Aug 28 17:40:02 CST 2023, time=2023-08-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2101893, encodeId=1c1321018936b, content=请问文章被接受了，想修改通讯作者地址可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b64882417, createdName=1186682916, createdTime=Tue Nov 22 09:01:32 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086418, encodeId=d55d1086418de, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086417, encodeId=6467108641ec7, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854192, encodeId=63dd85419249, content=投了一篇论文，大概两个月左右给了审稿意见，两位审稿人很专业很细致。要求半个月内返回修改稿，按照意见修改后，一周内接收。推荐病理方面的论文试一试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Fri Oct 11 09:31:49 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563762, encodeId=fe83563e6234, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：网上看到大家说这本杂志比较nice，就投了一篇免疫组化的文章。从投稿到外审拒稿只花了1个月的时间，两个外审专家的风格完全不同，第一个特别粗鲁，第二个特别nice，提出的问题也是比较零散。对语言的要求比较高，审稿周期还是很快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c1615298, createdName=Merlin4194, createdTime=Thu Nov 29 10:40:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847598, encodeId=21e184e59853, content=历史比较久的一个期刊，虽然近几年分数低了不少，还是一个很靠谱的期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Wed Oct 10 14:47:57 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539946, encodeId=330e53994612, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509113, encodeId=c217509113b3, content=这个杂志收录个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=559b1611420, createdName=lifan0819, createdTime=Tue Jan 13 18:27:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]

2018-11-29 Merlin4194

审稿速度:1.0 | 投稿命中率:25.0
经验分享：网上看到大家说这本杂志比较nice，就投了一篇免疫组化的文章。从投稿到外审拒稿只花了1个月的时间，两个外审专家的风格完全不同，第一个特别粗鲁，第二个特别nice，提出的问题也是比较零散。对语言的要求比较高，审稿周期还是很快的。

257 0

[GetPortalCommentsPageByObjectIdResponse(id=2179216, encodeId=cde021e92169e, content=11.6投稿 12.9修稿 12.14修回 12.29接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Jan 04 13:37:26 CST 2024, time=2024-01-04, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2154986, encodeId=142f21549861e, content=和病理相关的就行吗还是要以病理形态学为主 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c705729225, createdName=ms3000000555724543, createdTime=Mon Aug 28 17:40:02 CST 2023, time=2023-08-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2101893, encodeId=1c1321018936b, content=请问文章被接受了，想修改通讯作者地址可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b64882417, createdName=1186682916, createdTime=Tue Nov 22 09:01:32 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086418, encodeId=d55d1086418de, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086417, encodeId=6467108641ec7, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854192, encodeId=63dd85419249, content=投了一篇论文，大概两个月左右给了审稿意见，两位审稿人很专业很细致。要求半个月内返回修改稿，按照意见修改后，一周内接收。推荐病理方面的论文试一试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Fri Oct 11 09:31:49 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563762, encodeId=fe83563e6234, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：网上看到大家说这本杂志比较nice，就投了一篇免疫组化的文章。从投稿到外审拒稿只花了1个月的时间，两个外审专家的风格完全不同，第一个特别粗鲁，第二个特别nice，提出的问题也是比较零散。对语言的要求比较高，审稿周期还是很快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c1615298, createdName=Merlin4194, createdTime=Thu Nov 29 10:40:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847598, encodeId=21e184e59853, content=历史比较久的一个期刊，虽然近几年分数低了不少，还是一个很靠谱的期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Wed Oct 10 14:47:57 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539946, encodeId=330e53994612, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509113, encodeId=c217509113b3, content=这个杂志收录个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=559b1611420, createdName=lifan0819, createdTime=Tue Jan 13 18:27:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]

2018-10-10 ms4729674192825029

历史比较久的一个期刊，虽然近几年分数低了不少，还是一个很靠谱的期刊。

136 0

[GetPortalCommentsPageByObjectIdResponse(id=2179216, encodeId=cde021e92169e, content=11.6投稿 12.9修稿 12.14修回 12.29接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Jan 04 13:37:26 CST 2024, time=2024-01-04, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2154986, encodeId=142f21549861e, content=和病理相关的就行吗还是要以病理形态学为主 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c705729225, createdName=ms3000000555724543, createdTime=Mon Aug 28 17:40:02 CST 2023, time=2023-08-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2101893, encodeId=1c1321018936b, content=请问文章被接受了，想修改通讯作者地址可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b64882417, createdName=1186682916, createdTime=Tue Nov 22 09:01:32 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086418, encodeId=d55d1086418de, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086417, encodeId=6467108641ec7, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854192, encodeId=63dd85419249, content=投了一篇论文，大概两个月左右给了审稿意见，两位审稿人很专业很细致。要求半个月内返回修改稿，按照意见修改后，一周内接收。推荐病理方面的论文试一试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Fri Oct 11 09:31:49 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563762, encodeId=fe83563e6234, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：网上看到大家说这本杂志比较nice，就投了一篇免疫组化的文章。从投稿到外审拒稿只花了1个月的时间，两个外审专家的风格完全不同，第一个特别粗鲁，第二个特别nice，提出的问题也是比较零散。对语言的要求比较高，审稿周期还是很快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c1615298, createdName=Merlin4194, createdTime=Thu Nov 29 10:40:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847598, encodeId=21e184e59853, content=历史比较久的一个期刊，虽然近几年分数低了不少，还是一个很靠谱的期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Wed Oct 10 14:47:57 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539946, encodeId=330e53994612, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509113, encodeId=c217509113b3, content=这个杂志收录个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=559b1611420, createdName=lifan0819, createdTime=Tue Jan 13 18:27:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]

2017-07-18 yang_guoqiang2010

有所上涨，看好未来，大家认为呢？

423 0

[GetPortalCommentsPageByObjectIdResponse(id=2179216, encodeId=cde021e92169e, content=11.6投稿 12.9修稿 12.14修回 12.29接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210911/5888f6640265430b902b3fded856f491/788d7d25b2f7419ab0fab8df4239cea1.jpg, createdBy=c0775397989, createdName=凶巴巴恰北北怪兽, createdTime=Thu Jan 04 13:37:26 CST 2024, time=2024-01-04, status=1, ipAttribution=塔斯马尼亚), GetPortalCommentsPageByObjectIdResponse(id=2154986, encodeId=142f21549861e, content=和病理相关的就行吗还是要以病理形态学为主 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c705729225, createdName=ms3000000555724543, createdTime=Mon Aug 28 17:40:02 CST 2023, time=2023-08-28, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2101893, encodeId=1c1321018936b, content=请问文章被接受了，想修改通讯作者地址可以吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b64882417, createdName=1186682916, createdTime=Tue Nov 22 09:01:32 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086418, encodeId=d55d1086418de, content=引言三段式指的是什么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=76, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086417, encodeId=6467108641ec7, content=引言一般是三段式么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:47 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=854192, encodeId=63dd85419249, content=投了一篇论文，大概两个月左右给了审稿意见，两位审稿人很专业很细致。要求半个月内返回修改稿，按照意见修改后，一周内接收。推荐病理方面的论文试一试！ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c09a5414026, createdName=ms4662714744603927, createdTime=Fri Oct 11 09:31:49 CST 2019, time=2019-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563762, encodeId=fe83563e6234, content=审稿速度:1.0 | 投稿命中率:25.0 经验分享：网上看到大家说这本杂志比较nice，就投了一篇免疫组化的文章。从投稿到外审拒稿只花了1个月的时间，两个外审专家的风格完全不同，第一个特别粗鲁，第二个特别nice，提出的问题也是比较零散。对语言的要求比较高，审稿周期还是很快的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=257, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f68c1615298, createdName=Merlin4194, createdTime=Thu Nov 29 10:40:00 CST 2018, time=2018-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=847598, encodeId=21e184e59853, content=历史比较久的一个期刊，虽然近几年分数低了不少，还是一个很靠谱的期刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d2bd5414155, createdName=ms4729674192825029, createdTime=Wed Oct 10 14:47:57 CST 2018, time=2018-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539946, encodeId=330e53994612, content=有所上涨，看好未来，大家认为呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=423, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=yang_guoqiang2010, createdTime=Tue Jul 18 18:37:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=509113, encodeId=c217509113b3, content=这个杂志收录个案吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=474, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=559b1611420, createdName=lifan0819, createdTime=Tue Jan 13 18:27:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]

2015-01-13 lifan0819

这个杂志收录个案吗？

474 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务